openPR Logo
Press release

Viral Vector and Plasmid DNA Manufacturing Market - Increase in Awareness Regarding Viral and Non-Viral Vectors, And Investment in Research and Innovation Fuel the Demand for Market

02-26-2019 10:19 AM CET | Health & Medicine

Press release from: Allied Market Research

Viral Vector and Plasmid DNA Manufacturing Market

Viral Vector and Plasmid DNA Manufacturing Market

The Position for Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the Viral Vector and Plasmid DNA Manufacturing Market in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period.

Gene therapy has included tools such as viral vectors and plasmid DNA and has evolved into a treatment option that is favorable for a variety of diseases, particularly viral infections, cancers, and hereditary diseases, particularly those without current treatments. Gene therapy and genetically modified therapies involve the use of therapeutic DNA (the gene of interest) in the cell. The process of gene transfer into cells is done by the application of vectors. Over the last several years, several viral and nonviral plasmid DNA have been standardized and optimized for this purpose.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2681

The key market players operating in this market are
• Kaneka Eurogentec S.A.
• FinVector
• Brammer Bio
• Cell and Gene Therapy Catapult
• FUJIFILM Diosynth Biotechnologies
• Sanofi
• Spark Therapeutics
• Cobra Biologics
• UniQure and MassBiologics.

Other players in the value chain analysis include, 4D Molecular Therapeutics, Renova Therapeutics, Shenzhen SiBiono GeneTech Co., Ltd., and Thermo Fisher Scientific, Inc.

Key factors driving the global viral vector and plasmid DNA manufacturing market include the numerous stages of clinical progression, the ability of vectors to efficiently express therapeutic genes, and the rapid development of genes through non-pathogenesis of vectors.However, the high costs of possible mutagenesis and gene therapy inhibit market growth. Technological advances to mitigate the problems caused by traditional vector generation methods provide a good opportunity for manufacturers in this industry.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2681

The cancer application generated the highest revenue of $162 million in 2016, and is anticipated to continue this trend in the future. The requirement for quality drugs and versatile therapies for treatment are expected to boost the growth of this segment. Inherited disorders application is projected to grow at the highest CAGR of 25.1% from 2017 to 2023.

North America held the highest market share of $124 million in 2016, owing to high prevalence rate of cancer and modern healthcare facilities. The adoption of experimental medicines and growth in awareness about gene therapy are expected to boost the North American market. Asia-Pacific is expected to grow at the highest CAGR of 18.8% during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize healthcare infrastructure.

Key Findings of the Viral Vector and Plasmid DNA Manufacturing Market:
• The plasmid DNA segment is anticipated to grow at the highest CAGR from 2017 to 2023.
• The inherited disorders application segment is expected to witness the highest growth rate.
• Cancer application segment is anticipated to occupy the largest share in the viral vector and plasmid DNA manufacturing market.
• North America dominated the global viral vector and plasmid DNA manufacturing market, and is projected to grow at a CAGR of 20.6%.

Access Full Summery @ https://www.alliedmarketresearch.com/viral-vectors-and-plasmid-DNA-manufacturing-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Vector and Plasmid DNA Manufacturing Market - Increase in Awareness Regarding Viral and Non-Viral Vectors, And Investment in Research and Innovation Fuel the Demand for Market here

News-ID: 1616723 • Views: 132

More Releases from Allied Market Research

Envelope Tracking Chip Market Trends and Analysis (2021-2028): Top Impacting Fac …
Allied Market Research published a new report, titled, "Envelope Tracking Chip Market By Technology (Cellular Communications, Wireless Communications, and Satellite Communications), Application (Smart Phones, Wearable Devices, and Others), and End User (Consumer Electronics, Space and Aviation, Automotive, Telecommunications, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a detailed study of the global envelope tracking chip market covering a number of important aspects such as current market scenario,
Enterprise Asset Leasing Market Growth Opportunities (2021-2028): Market Share a …
Allied Market Research published a new report, titled, "Enterprise Asset Leasing Market By Asset Type (Commercial Vehicles, Machinery & Industrial Equipment, Real Estate, IT Equipment and Others), Leasing Type (Operating Lease and Financial Lease), Industry Vertical (Transportation & Logistics, Manufacturing, Construction, IT & Telecom, Government & Public Sector and Others) and Enterprise Size (Large Enterprises and Small and Medium Enterprises): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a
High Performance Computing (HPC) Chipset Market Trends (2021-2028): Key Market D …
Allied Market Research published a new report, titled, "High Performance Computing (HPC) Chipset Market By Chip Type (CPU, GPU, FPGA, and ASIC): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a detailed study of the global HPC chipset market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent trends, changing dynamics, and vibrant forces of the industry from 2019 to 2028 to
Accelerometer and Gyroscope Market Current Updates (2021-2028): Growth Opportuni …
Allied Market Research published a new report, titled, "Accelerometer and Gyroscope Market By Type (Accelerometer and Gyroscope), Dimension (1-Axis, 2-Axis, and 3-Axis), and Industry Vertical (Consumer Electronics, Automotive, Aerospace & Defense, Industrial, and Healthcare) - Global Opportunity Analysis and Industry Forecast, 2020-2028". The report provides a detailed study of the global accelerometer and gyroscope market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent

All 5 Releases


More Releases for DNA

Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have
Synbio Technologies Revolutionizes DNA Synthesis
DNA Synthesis Definition and Methods DNA synthesis definition DNA synthesis is defined as the process by which copies of nucleic acids are strung together to form a longer DNA sequence within a laboratory setting. DNA synthesis processes DNA oligomers are the foundation of the DNA synthesis process. The essential feature of DNA synthesis is that no naturally isolated DNA is used. This step deviates from the traditional method of studying genetics, by which a
Global DNA Vaccine Pipeline Analysis
he global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena. At present, not even a single DNA vaccine has been approved for human beings. However, around 100 products are under clinical trial for treating diseases like HIV infection, cancer and other infectious diseases. With regards to animal health, there are three
Global DNA Sequencing Market Report
MarketResearchReports.Biz announces addition of new report “Global DNA Sequencing Market Report: 2015 Edition” to its database. Description DNA sequencing market is one of the fastest growing segments of the life sciences tools market. This research study includes the market assessment of various products, technologies, applications and end-users. The report briefs about the classification in genomics, process of transcription and translation of DNA, historical development, and generations of sequencing technologies. The sequencing industry is
Global DNA Sequencing Market Report
MarketResearchReports.Biz announces addition of new report “Global DNA Sequencing Market Report: 2015 Edition” to its database. Description DNA sequencing market is one of the fastest growing segments of the life sciences tools market. This research study includes the market assessment of various products, technologies, applications and end-users. The report briefs about the classification in genomics, process of transcription and translation of DNA, historical development, and generations of sequencing technologies. The sequencing industry is
DNA Chip and DNA microarray industry NextGen Frontier for DNA Technologies – I …
A report from Transparency Market Research, titled ‘DNA Chip Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,’ states that the global DNA chip market is expected to expand at a rapid pace during the period from 2015 to 2023 due to the increasing prevalence of cancer, the growth in personalized medicines, and technological advancements. A DNA chip, also known as a DNA microarray,